| Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ... The Lancet 378 (9809), 2081-2087, 2011 | 1143 | 2011 |
| Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register JI Morrow, A Russell, E Guthrie, L Parsons, I Robertson, R Waddell, ... Journal of Neurology, Neurosurgery & Psychiatry 77 (2), 193-198, 2006 | 1121 | 2006 |
| Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE N Mavaddat, S Peock, D Frost, S Ellis, R Platte, E Fineberg, DG Evans, ... JNCI: Journal of the National Cancer Institute 105 (11), 812-822, 2013 | 1108 | 2013 |
| Phenotypic characterization of individuals with 30–40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals … DC Rubinsztein, J Leggo, R Coles, E Almqvist, V Biancalana, ... American journal of human genetics 59 (1), 16, 1996 | 702 | 1996 |
| Germline mutations in RAD51D confer susceptibility to ovarian cancer C Loveday, C Turnbull, E Ramsay, D Hughes, E Ruark, JR Frankum, ... Nature genetics 43 (9), 879-882, 2011 | 617 | 2011 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 567 | 2015 |
| Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dube syndrome LS Schmidt, ML Nickerson, MB Warren, GM Glenn, JR Toro, MJ Merino, ... The American Journal of Human Genetics 76 (6), 1023-1033, 2005 | 442 | 2005 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 430 | 2012 |
| Tumor risks and genotype–phenotype–proteotype analysis in 358 patients with germline mutations in SDHB and SDHD CJ Ricketts, JR Forman, E Rattenberry, N Bradshaw, F Lalloo, L Izatt, ... Human mutation 31 (1), 41-51, 2010 | 409 | 2010 |
| Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate … NA Alam, AJ Rowan, NC Wortham, PJ Pollard, M Mitchell, JP Tyrer, ... Human molecular genetics 12 (11), 1241-1252, 2003 | 377 | 2003 |
| Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome J Burn, DT Bishop, JP Mecklin, F Macrae, G Möslein, S Olschwang, ... New England Journal of Medicine 359 (24), 2567-2578, 2008 | 365 | 2008 |
| Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers E Campbell, F Kennedy, A Russell, WH Smithson, L Parsons, PJ Morrison, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (9), 1029-1034, 2014 | 339 | 2014 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 332 | 2013 |
| Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register S Hunt, A Russell, WH Smithson, L Parsons, I Robertson, R Waddell, ... Neurology 71 (4), 272-276, 2008 | 318 | 2008 |
| Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind … J Burn, H Sheth, F Elliott, L Reed, F Macrae, JP Mecklin, G Möslein, ... The Lancet 395 (10240), 1855-1863, 2020 | 316 | 2020 |
| Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3 MA Nesbit, FM Hannan, SA Howles, AAC Reed, T Cranston, CE Thakker, ... Nature genetics 45 (1), 93-97, 2013 | 281 | 2013 |
| Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer E Ruark, K Snape, P Humburg, C Loveday, I Bajrami, R Brough, ... Nature 493 (7432), 406-410, 2013 | 275 | 2013 |
| Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ... Cancer research 70 (23), 9742-9754, 2010 | 259 | 2010 |
| Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics AC Antoniou, R Hardy, L Walker, DG Evans, A Shenton, R Eeles, ... Journal of medical genetics 45 (7), 425-431, 2008 | 232 | 2008 |
| Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers E Mawhinney, J Craig, J Morrow, A Russell, WH Smithson, L Parsons, ... Neurology 80 (4), 400-405, 2013 | 230 | 2013 |
Evans DG*, Evans G*University of Manchester在 mft.nhs.uk 的电子邮件经过验证
